Healthcare and Life Science
ELRIG appoints Dr Kelly Gray and Dr Elaine Duncan to its Board
*Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community *Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively ...
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized healthcare settingsBuilds on success of existing partnership including development of automated library preparation methods ...
This PowerPoint feature has disappeared
If your team creates presentations often, you may have noticed a recent change in Microsoft PowerPoint.Microsoft has quietly removed a feature that helped you keep your branding and formatting consistent.Here’s what this means for you:Your slides may no longer stay aligned with your bra...
How AI is transforming surgical decision support
Artificial intelligence is emerging as one of the most influential forces reshaping modern surgical practice. Over the past decade, surgical teams have faced rising complexity in cases, expanding volumes of clinical data and increasing expectations surrounding accuracy, safety and effic...
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of developmentData confirms dual mechanism of action, including activation of tissue repair pathways in chronic woundsC...
Why Human Factors Will Drive Business Growth in 2026
When was the last time you abandoned a product because it was frustrating to use? When products are frustrating to use, users will abandon them, share their discontent or fail to adopt them in the first place.For start-ups, that could mean losing customers or a potential investment oppo...
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infectionsInvestment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and diagnostics extend...
Announcing the inaugural Imposter Phenomenon Awareness Day
Dr Kate Atkin and Dr Terri Simpkin are launching the inaugural International Imposter Phenomenon Awareness Day on Friday 27th February. Why phenomenon and not Syndrome? Because words matter and they can give you power to change or take it away. ...
Syndex Bio unveils mcPCR Technology at AGBT 2026 following $15.5M seed financing
• mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research• Launch follows ...
Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) announces a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance nutrition.The agreement with SiS, the glo...